Journal Article

Screening and Quantitative Determination of Twelve Acidic and Neutral Pharmaceuticals in Whole Blood by Liquid-Liquid Extraction and Liquid Chromatography-Tandem Mass Spectrometry

Kirsten Wiese Simonsen, Anni Steentoft, Maike Buck, Lene Hansen and Kristian Linnet

in Journal of Analytical Toxicology

Volume 34, issue 7, pages 367-373
Published in print September 2010 | ISSN: 0146-4760
Published online September 2010 | e-ISSN: 1945-2403 | DOI: http://dx.doi.org/10.1093/jat/34.7.367
Screening and Quantitative Determination of Twelve Acidic and Neutral Pharmaceuticals in Whole Blood by Liquid-Liquid Extraction and Liquid Chromatography-Tandem Mass Spectrometry

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

We describe a multi-method for simultaneous identification and quantification of 12 acidic and neutral compounds in whole blood. The method involves a simple liquid-liquid extraction, and the identification and quantification are performed using liquid chromatography-tandem mass spectrometry. The method was fully validated for salicylic acid, paracetamol, phenobarbital, carisoprodol, meprobamate, topiramate, etodolac, chlorzoxazone, furosemide, ibuprofen, warfarin, and salicylamide. The method also tentatively includes thiopental, theophylline, piroxicam, naproxen, diclophenac, and modafinil, but these drugs were not included in the full validation program and are not described in detail here. Limit of quantitation was 1 mg/kg for the compounds with coefficients of variation of < 20%, except for furosemide, which had a coefficient of variation of 32% at limit of quantitation. The measuring interval was wide for most components. Extraction efficiencies were high, reflecting the high-yield capacity of the method.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.